Analyst Reco. Ionis Pharmaceuticals, Inc.

Equities

IONS

US4622221004

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
43.01 ^USD	+4.24%		+1.32%	-14.98%

04-11	North American Morning Briefing : Stock Futures -2-	DJ
04-10	Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform	04-10	MT
Oppenheimer Raises Ionis Pharmaceuticals' Price Target to $75 From $72, Maintains Outperform Rating	04-09	MT
Oppenheimer Adjusts Ionis Pharmaceuticals Price Target to $72 From $65, Maintains Outperform Rating	03-06	MT
Oppenheimer Adjusts Ionis Pharmaceuticals Price Target to $65 From $63, Maintains Outperform Rating	02-26	MT
JPMorgan Chase Adjusts Price Target on Ionis Pharmaceuticals to $55 From $52, Maintains Neutral Rating	02-01	MT
RBC Lifts Price Target on Ionis Pharmaceuticals to $70 From $65, Says Survey Suggests Wainua Launch May Surprise to Upside; Outperform Kept	01-26	MT
Piper Sandler Adjusts Ionis Pharmaceuticals' Price Target to $62 From $60, Maintains Overweight Rating	01-18	MT
BofA Securities Upgrades Ionis Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $62 From $52	01-02	MT
Stifel Adjusts Price Target on Ionis Pharmaceuticals to $50 From $45, Maintains Hold Rating	12-18	MT
Goldman Sachs Raises Price Target on Ionis Pharmaceuticals to $28 From $25, Maintains Sell Rating	11-03	MT
Morgan Stanley Adjusts Price Target on Ionis Pharmaceuticals to $48 From $45, Maintains Equalweight Rating	11-03	MT
BofA Securities Upgrades Ionis Pharmaceuticals to Neutral From Underperform	23/10/23	MT
Raymond James Initiates Ionis Pharmaceuticals With Strong Buy Rating, Price Target is $63	29/09/23	MT
Morgan Stanley Adjusts Price Target on Ionis Pharmaceuticals to $45 From $42, Maintains Equalweight Rating	27/09/23	MT
Fed Rate Outlook Lifts Exchange-Traded Funds, Equity Futures Premarket Wednesday	09/08/23	MT
Citigroup Upgrades Ionis Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $60 From $36	31/07/23	MT
Barclays Adjusts Price Target on Ionis Pharmaceuticals to $37 From $40, Maintains Equalweight Rating	04/05/23	MT
Citigroup Upgrades Ionis Pharmaceuticals to Neutral From Sell, Raises Price Target to $36 From $30	04/05/23	MT
Wells Fargo Adjusts Ionis Pharmaceuticals Price Target to $88 From $92, Maintains Overweight Rating	04/05/23	MT
Powell's mixed signals and Pacwest weigh on US indices	04/05/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ionis Pharmaceuticals, Inc.

Equities

IONS

US4622221004

Analyst Reco.

Filters